Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:
Katten‘s ’patent litigation practice specializes in Hatch-Waxman cases for leading generic drug companies. Recently, the team worked on a high-profile case representing Sun Pharmaceutical Industries in defending their generic version of Ozempic. Deepro Mukerjee, based in New York, is ‘a stand-out patent litigator’ who oversees trial and appellate proceedings. Mukerjee also has experience managing IPR proceedings before the PTAB. Mukerjee chairs the department alongside New-York-based Lance Soderstrom, a seasoned litigator with expertise in pharmaceutical compounds and medical devices, and Chicago-based Brian Sodikoff, who also focuses on Hatch-Waxman patent litigation, drawing on his background in competition law.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Extremely competent group of attorneys, led by Mr Deepro Mukerjee. They use common sense, value-driven billing with an eye towards results.’
‘Mr. Deepro Mukerjee is a stand-out patent litigator, immensely talented and results-driven, and leader of the patent litigation team at Katten. He has a keen understanding of his client's business needs and focuses his advice on a legal and business perspective. ’
Kernmandanten
- Apotex Corp. / Apotex Inc.
- Avocados Plus
Highlight-Mandate
- Representing Sun Pharmaceutical Industries (Sun) in a patent lawsuit involving Ozempic, a popular diabetes drug that people also take for weight loss.
- Representing Sun Pharmaceutical Industries (Sun) in a patent lawsuit involving Wegovy, an injectable weight-loss medication for adults with obesity or excess weight with weight-related conditions.